151 related articles for article (PubMed ID: 28712790)
1. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance-A systematic review.
Zengerling F; Kunath F; Jensen K; Ruf C; Schmidt S; Spek A
Urol Oncol; 2018 Oct; 36(10):448-458. PubMed ID: 28712790
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance--protocol for a systematic review.
Kunath F; Spek A; Jensen K; Zengerling F; Schmidt S
Syst Rev; 2015 Dec; 4():182. PubMed ID: 26684760
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
[TBL] [Abstract][Full Text] [Related]
4. Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel.
Boormans JL; Mayor de Castro J; Marconi L; Yuan Y; Laguna Pes MP; Bokemeyer C; Nicolai N; Algaba F; Oldenburg J; Albers P
Eur Urol; 2018 Mar; 73(3):394-405. PubMed ID: 29100813
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.
Chung P; Daugaard G; Tyldesley S; Atenafu EG; Panzarella T; Kollmannsberger C; Warde P
Cancer Med; 2015 Jan; 4(1):155-60. PubMed ID: 25236854
[TBL] [Abstract][Full Text] [Related]
6. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
[TBL] [Abstract][Full Text] [Related]
7. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
[TBL] [Abstract][Full Text] [Related]
9. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors for Relapse in Patients With Clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study.
Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Rosenvilde JJ; Berney D; Daugaard G
J Clin Oncol; 2024 Jan; 42(1):81-89. PubMed ID: 37683134
[TBL] [Abstract][Full Text] [Related]
11. Intertubular growth in pure seminomas: associations with poor prognostic parameters.
Browne TJ; Richie JP; Gilligan TD; Rubin MA
Hum Pathol; 2005 Jun; 36(6):640-5. PubMed ID: 16021570
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited.
Aparicio J
Clin Transl Oncol; 2018 Oct; 20(10):1358-1359. PubMed ID: 29744734
[No Abstract] [Full Text] [Related]
13. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans JL; Sylvester R; Anson-Cartwright L; Glicksman RM; Hamilton RJ; Hahn E; Daugaard G; Lauritsen J; Wagner T; Avuzzi B; Nicolai N; Del Muro XG; Aparicio J; Stalder O; Rothermundt C; Fischer S; Laguna MP
Eur Urol Oncol; 2024 Jun; 7(3):537-543. PubMed ID: 37951820
[TBL] [Abstract][Full Text] [Related]
14. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).
Tandstad T; Ståhl O; Dahl O; Haugnes HS; Håkansson U; Karlsdottir Å; Kjellman A; Langberg CW; Laurell A; Oldenburg J; Solberg A; Söderström K; Stierner U; Cavallin-Ståhl E; Wahlqvist R; Wall N; Cohn-Cedermark G;
Ann Oncol; 2016 Jul; 27(7):1299-304. PubMed ID: 27052649
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
[TBL] [Abstract][Full Text] [Related]
16. Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center.
Tyrrell HEJ; Church DN; Joseph J; Traill ZC; Sullivan ME; Tuthill MH; Verrill CL; Pintus EP; Dallas NL; Rogers PB; Redgwell J; Protheroe AS
Clin Genitourin Cancer; 2018 Jun; 16(3):240-244. PubMed ID: 29336917
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of tumour size and rete testis invasion in progression free survival of our patients with stage i testicular seminoma. A retrospective observational study of a reference hospital center and literature review.
Yáñez-Castillo YM; Melgarejo-Segura MT; Gutiérrez-Tejero F; Arrabal-Martín M
Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):654-660. PubMed ID: 37355209
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance.
Parker C; Milosevic M; Panzarella T; Banerjee D; Jewett M; Catton C; Tew-George B; Gospodarowicz M; Warde P
Eur J Cancer; 2002 Oct; 38(15):2014-9. PubMed ID: 12376206
[TBL] [Abstract][Full Text] [Related]
19. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era.
Yuasa T; Inoshita N; Tanaka H; Urakami S; Yamamoto S; Fujii Y; Masuda H; Fukui I; Ishikawa Y; Yonese J
Int J Clin Oncol; 2015 Dec; 20(6):1198-202. PubMed ID: 25893862
[TBL] [Abstract][Full Text] [Related]
20. Stage II testicular seminoma: patterns of recurrence and outcome of treatment.
Chung PW; Gospodarowicz MK; Panzarella T; Jewett MA; Sturgeon JF; Tew-George B; Bayley AJ; Catton CN; Milosevic MF; Moore M; Warde PR
Eur Urol; 2004 Jun; 45(6):754-59; discussion 759-60. PubMed ID: 15149748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]